Trazodone, a central serotonin antagonist and agonist.

Area of Science:

• Neuropharmacology
• Serotonin System Research
• Antidepressant Drug Mechanisms

Background:

• The mechanism of action for trazodone (TR), a non-tricyclic antidepressant, remains unclear.
• Investigating TR's effects on the serotonin (5-HT) system is crucial for understanding its therapeutic actions.

Purpose of the Study:

• To elucidate the impact of trazodone (TR) and its metabolites, OTPA and CPP, on the central 5-HT system.
• To analyze the dose-dependent effects of TR on the hind limb flexor reflex in a spinal rat model.

Main Methods:

• Utilized a spinal rat hind limb flexor reflex model to assess drug effects.
• Administered trazodone (TR), OTPA, and CPP at varying doses.
• Evaluated the influence of serotonergic agents (LSD, quipazine, fenfluramine) and receptor blockers (cyproheptadine, WA-335, metergoline, imipramine).

Main Results:

• Low-dose TR (1 mg/kg) antagonized serotonergic stimulation of the flexor reflex.
• High-dose TR (6-8 mg/kg) enhanced the reflex, an effect blocked by 5-HT antagonists but not imipramine.
• The metabolite CPP (0.05-1 mg/kg) significantly enhanced the reflex, with similar antagonism by 5-HT blockers.

Conclusions:

• Trazodone (TR) demonstrates a dual role in the central 5-HT system: antagonistic at low doses and agonistic at higher doses.
• The agonist effect at higher doses may be mediated by the metabolite CPP or related compounds.
• Findings suggest a complex interaction between trazodone, its metabolites, and the serotonin system.